𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting

✍ Scribed by Dubey, Praveen K.; Mishra, Vivek; Jain, Sanyog; Mahor, Sunil; Vyas, S.P.

Book ID
111885337
Publisher
Informa plc
Year
2004
Tongue
English
Weight
232 KB
Volume
12
Category
Article
ISSN
1061-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo platelet targeting
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes
✍ Rekha Srinivasan; Roger E. Marchant; Anirban Sen Gupta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

## Abstract Cell‐selective delivery using ligand‐decorated nanoparticles is a promising modality for treating cancer and vascular diseases. We are developing liposome nanoparticles surface‐modified by RGD peptide ligands having targeting specificity to integrin GPIIb‐IIIa. This integrin is upregula

Cyclic RGD-Containing Functionalized Aza
Cyclic RGD-Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting
✍ Leonardo Manzoni; Laura Belvisi; Daniela Arosio; Monica Civera; Michael Pilkingt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

## Abstract Vitronectin receptors α~v~β~3~ and α~v~β~5~ have emerged as potential therapeutic targets for the treatment of osteoporosis, restenosis, ocular disease, tumor‐induced angiogenesis, metastasis, and sickle‐cell anemia. Among a collection of compounds, a new potent integrin antagonist was